Insecticides (India) Limited (INSECTICID) — Financial Results(5 announcements)

· NSE 🔴 High Importance Neutral
1 Financial Results 🔴 High Importance Neutral 📄 PDF

Investor Takeaways

  • Reported consolidated net loss of Rs. (76.03) lakhs in FY2026 versus Rs. 459.65 lakh profit in FY2025.
  • Cash flow from operations increased to Rs. 13,633.85 lakhs in FY2026.
  • Appointed Sanskar Aggarwal as Whole-Time Director effective May 28, 2026; Nikunj Aggarwal resigned same day.
  • Dissolved Dubai subsidiary during the fiscal year.
  • Unmodified auditor's opinion confirmed for FY2026.
  • Overall Tone: Cautious

    Key Financial Highlights

    MetricValueYoY Change
    Revenue₹2,931.60 lakhsN/A
    Net Profit₹(76.03) lakhsDecline from ₹459.65 lakh profit
    Cash Flow from Operations₹13,633.85 lakhsImproved from prior year
    EPSNot availableN/A
    OPMNot availableN/A

    What Changed

    The company reversed from a profit of Rs. 459.65 lakh in FY2025 to a net loss of Rs. (76.03) lakhs in FY2026, indicating a significant deterioration in profitability. Despite this, cash flow from operations strengthened to Rs. 13,633.85 lakhs, suggesting improved operational liquidity. The board approved the audited FY2026 results, appointed Sanskar Aggarwal as Whole-Time Director, and accepted Nikunj Aggarwal’s resignation effective May 28, 2026. Additionally, the company dissolved its Dubai subsidiary during the fiscal year, which may have impacted financials. The unmodified auditor's opinion confirms no material reservations in the financial statements.

    Peer Comparison

    CompanyP/EROEROCEMarket Cap (₹ Cr)
    Insecticides (India) Limited15.74N/AN/A2,103.19
    Solar Industries India Limited132.27N/AN/A1,56,674.48
    Pidilite Industries Limited75.73N/AN/A1,49,378.89
    SRF Limited69.51N/AN/A79,723.46

    The company trades at a significantly lower P/E ratio compared to peers like Solar Industries, Pidilite, and SRF, suggesting potential undervaluation or lower market expectations. However, peers' ROE and ROCE data are not available for direct comparison.

    Risks & Concerns

  • Net loss of Rs. (76.03) lakhs marks a sharp decline from prior year’s profit, signaling potential operational or market challenges.
  • No specific risks detailed in the filing; however, the profitability reversal warrants monitoring.
  • Quarterly Trend

    QuarterRevenue (₹ Cr)Net Profit (₹ Cr)OPM%
    Q3FY25357.717.368.64
    Q2FY25627.0961.4914.28
    Q1FY25656.6949.0110.89
    Q4FY24272.57.763.28

    The quarterly trend shows fluctuating profitability, with Q2FY25 delivering the highest profit (₹61.49 Cr) and Q4FY24 the lowest (₹7.76 Cr). OPM declined from 14.28% in Q2FY25 to 3.28% in Q4FY24, indicating margin pressure in the final quarter. The FY2026 net loss appears to be an outlier compared to recent quarterly performance, which showed consistent profits and improving margins in earlier quarters. The annual loss may reflect exceptional items or one-time adjustments not captured in quarterly trends.

    2 Financial Results 🔴 High Importance Neutral 📄 PDF
    Revenue: ₹42,795.6 CrNet Profit: ₹13.64 L Cr
    📢 Key Event
    Board approves FY2026 audited results and appoints new Whole-Time Director
    🔄 What Changed
    Net profit of ₹1,170.99 crores; cash flow from operations of ₹10,872.41 crores
    💡 Investor Takeaway
    The company delivered strong profitability and cash generation despite management changes, supporting shareholder value through robust financial performance.

    The Board approved audited FY2026 financial results showing revenue of ₹4,262.60 crores, profit before tax of ₹3,300.33 crores, and net profit of ₹1,170.99 crores with EPS of [amount not verified]. Cash flow from operations reached ₹10,872.41 crores, while net cash increased by ₹3,174.50 crores after outflows in investing and financing activities. The filing also details management changes including the resignation of Whole-Time Director Nikunj Aggarwal and appointments of Sanskar Aggarwal as Whole-Time Director (Additional) and Atul Kumar as Vice President-Sales (North).

    3 Financial Results 🔴 High Importance Neutral 📄 PDF
    Revenue: ₹359 CrNet Profit: ₹1,412 Cr
    📢 Key Event
    Insecticides (India) Limited announced Q4 and FY26 financial results with revenue growth and stable margins.
    🔄 What Changed
    Revenue grew 19% YoY in Q4 FY26 to ₹2,140 crores and 7% YoY for FY26 to ₹2,000 crores; gross profit margin held at 31.5% for FY26; EBITDA margin fell to 10.6% in Q4 FY26.
    🔮 What's Next
    The company plans to strengthen its product pipeline, expand strategic collaborations, premiumize brand equity, deepen dealer and farmer engagement, and drive innovative marketing initiatives.
    💡 Investor Takeaway
    Shareholders see growth in revenue and stable margins despite challenging conditions, supported by new product launches and expanded market reach.

    Insecticides (India) Limited reported consolidated revenue of ₹2,140 crores for Q4 FY26, a 19% YoY increase, and ₹2,000 crores for FY26, a 7% YoY rise. Gross profit margin stabilized at 31.5% for FY26 versus 32% in FY25, while EBITDA margin declined to 10.6% in Q4 FY26 from 11.1% in Q4 FY25. The company highlighted new product launches, including Granuvia with Corteva, and strong farmer engagement across 26,000+ meetings.

    4 Financial Results 🔴 High Importance ✨ Positive 📄 PDF
    📢 Key Event
    FY26 revenue reached ₹2,140 crores with 7% YoY growth.
    🔄 What Changed
    Gross profit margin improved to 31.5% (from 23.1%), EBITDA margin rose to 10.6% (from 6.8%), and PAT margin increased to 6.5% (from 6.9%). Premium product share in B2C sales grew to 58% (from 51%).
    🔮 What's Next
    The company plans to expand premium product launches and strengthen R&D capabilities to drive sustainable growth.
    💡 Investor Takeaway
    Premiumization is accelerating profitability and market share, signaling strong long-term growth potential for shareholders.

    Insecticides (India) Limited reported FY26 revenue of ₹2,140 crores, up 7% YoY, with gross profit margin expanding to 31.5% and EBITDA margin improving to 10.6%. PAT margin stood at 6.5%, reflecting stable profitability. The company highlighted premiumization driving growth, with premium products contributing 58% of B2C sales. Key financials include revenue of ₹2,140 crores (FY26), gross profit of ₹675 crores, EBITDA of ₹227 crores, and PAT of ₹139 crores. The presentation emphasized robust distribution reach (8,500+ distributors, 75,00,000+ farmers) and strategic R&D investments.

    5 Financial Results 🔴 High Importance Neutral 📄 PDF
    Revenue: ₹42,795.6 CrNet Profit: ₹1.36 L Cr
    📢 Key Event
    Board approves FY2026 results, appoints new directors and auditor, and schedules AGM for August 12, 2026
    💡 Investor Takeaway
    Shareholders must approve the new appointments and ESOP scheme at the upcoming AGM, making this a procedural but important governance update requiring voter participation.

    Insecticides (India) Limited announced approval of FY2026 audited financial results and key leadership changes including the appointment of Sanskar Aggarwal as Whole-Time Director and Atul Kumar as Vice President-Sales (North), alongside the resignation of Nikunj Aggarwal effective May 28, 2026. The filing also confirmed the appointment of T Jain & Associates as Internal Auditor and detailed the Employee Stock Purchase Scheme 2026 requiring shareholder approval at the upcoming AGM. The Board approved the financial statements and new appointments during its May 28 meeting, with the AGM scheduled for August 12, 2026, to ratify these changes and the auditor appointments.

    About Insecticides (India) Limited (INSECTICID)

    Chemicals · Fertilizers & Agrochemicals · Listed on NSE

    Market Cap: ₹2,103.19 Cr P/E: 15.7

    View full INSECTICID stock details →

    📡 Get AI alerts when INSECTICID files next

    Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

    Track INSECTICID — Free

    📊 More INSECTICID filings

    See all INSECTICID filings →

    Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

    📡 Get AI alerts when INSECTICID files new disclosures

    Track INSECTICID filings, board meetings, and corporate actions. Free email alerts at 5 PM.

    Track INSECTICID — Free

    Free account · 2 AI queries/day